Proposed morphologic classification of prostate cancer with neuroendocrine differentiation

JI Epstein, MB Amin, H Beltran, TL Lotan… - The American journal …, 2014 - journals.lww.com
Abstract On July 31, 2013, the Prostate Cancer Foundation assembled a working committee
on the molecular biology and pathologic classification of neuroendocrine (NE) differentiation
in prostate cancer. New clinical and molecular data emerging from prostate cancers treated
by contemporary androgen deprivation therapies, as well as primary lesions, have
highlighted the need for refinement of diagnostic terminology to encompass the full spectrum
of NE differentiation. The classification system consists of: Usual prostate adenocarcinoma …